Home › Compare › ANPDF vs ABBV
ANPDF yields 2.91% · ABBV yields 3.06%● Live data
📍 ANPDF pulled ahead of the other in Year 3
Combined, ANPDF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ANPDF + ABBV for your $10,000?
ANTA Sports Products Limited, together with its subsidiaries, designs, develops, manufactures, and markets sporting footwear, apparel, and accessories worldwide. The company offers sportswear, including running, cross-training, basketball, soccer, boxing, winter sports, boxing, taekwondo, gymnastics, weightlifting, wrestling, outdoor sports, women's fitness, and skiing products, as well as sports fashion clothing, kid's sports fashion clothing and sportswear, and leisure footwear products under the FILA, FILA KIDS, FILA FUSION, KINGKOW, KOLON SPORT, SPRANDI, FILA FUSION, ANTA, DESCENTE, and ANTA KIDS brands. It also provides management, product design, logistics, and information technology services; manufactures shoe soles; holds trademarks; and develops and manages properties. As of December 31, 2021, it operated 9,403 ANTA stores; 2,054 FILA stores; 182 DESCENTE stores; and 152 KOLON SPORT stores. It also exports and imports sporting shoes. The company was founded in 1991 and is headquartered in Jinjiang, the People's Republic of China. ANTA Sports Products Limited is a subsidiary of Anta International Group Holdings Limited.
Full ANPDF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.